Republic of Korea vs United Kingdom of Great Britain and Northern Ireland: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Republic of Korea
0.0%
in 2024
United Kingdom of Great Britain and Northern Ireland
0.0%
in 2024
Republic of Korea rank
167th
United Kingdom of Great Britain and Northern Ireland rank
167th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Republic of Korea
- United Kingdom of Great Britain and Northern Ireland
How they compare
Republic of Korea currently reports 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was United Kingdom of Great Britain and Northern Ireland ahead.
Republic of Korea ranks 167th and United Kingdom of Great Britain and Northern Ireland ranks 167th of 246 countries.
Republic of Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Republic of Korea | United Kingdom of Great Britain and Northern Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | Republic of Korea |
| 2020s | 0.0% | 0.0% | 0.0% | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Republic of Korea or United Kingdom of Great Britain and Northern Ireland?
- Republic of Korea, at 0.0% against 0.0% in United Kingdom of Great Britain and Northern Ireland as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Republic of Korea and United Kingdom of Great Britain and Northern Ireland?
- 0.0%, with Republic of Korea ahead.
- How many years of comparable data are there for Republic of Korea and United Kingdom of Great Britain and Northern Ireland?
- 10 years are reported by both, from 2015 to 2024.
- How do Republic of Korea and United Kingdom of Great Britain and Northern Ireland rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Republic of Korea ranks 167th and United Kingdom of Great Britain and Northern Ireland ranks 167th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.